Company / Revenue per Share
Kiniksa Pharmaceuticals International, plc Revenue per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$9.42
FY2025
5-year range
$0.71 / $9.42
FY2021-FY2025
Trend
+56.7%
vs FY2024
Sector context
#47 of 154
Health Care
What the data says
At $9.42, Kiniksa Pharmaceuticals International, plc's revenue per share ranks #47 of 154 in the Health Care sector. Revenue per Share has increased for 4 consecutive years, from $0.71 in FY2021 to $9.42 in FY2025.
Based on SEC 10-K filings.
9.42 in FY2025 with a 3-year CAGR of +38.3%.
Improved from $3.94 to $9.42 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +38.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#47 of 154 in Health CareTop 31% of 154This company $9.42 Sector average $10.35
▼
-9.0% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's revenue per share has grown for 4 consecutive years.
- In FY2025, revenue per share increased 56.7% year-over-year.
- Ranks #47 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.42 | +56.7% |
| FY2024 | $6.01 | +52.5% |
| FY2023 | $3.94 | +10.7% |
| FY2022 | $3.56 | +399.3% |
| FY2021 | $0.71 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026